12/20/2024
1:28 PM | Ionis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
7:34 PM | BB BIOTECH AG (Filed by)
Ionis Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/13/2024
7:55 AM | Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
| Form 144/A | |
11/08/2024
9:52 AM | Ionis Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G | |
11/06/2024
3:06 PM | Ionis Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
10:15 AM | Ionis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
5:39 PM | Devers Shannon L. (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
10/17/2024
5:42 PM | Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
5:01 PM | Devers Shannon L. (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/01/2024
5:01 PM | Devers Shannon L. (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
4:19 PM | Ionis Pharmaceuticals (Filer)
| Form 424B5 | |
09/09/2024
3:33 PM | Ionis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2024
3:23 PM | Ionis Pharmaceuticals (Filer)
| Form 424B5 | |
09/04/2024
8:43 PM | Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
8:43 PM | Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
8:51 PM | Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
8:23 PM | Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
| Form 144/A | |
09/04/2024
8:24 PM | Ionis Pharmaceuticals (Subject)
O'NEIL PATRICK R. (Reporting)
| Form 144/A | |
09/04/2024
8:25 PM | HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144/A | |
09/04/2024
8:27 PM | BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144/A | |
09/04/2024
8:29 PM | Cadoret-Manier Onaiza (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144/A | |
09/04/2024
8:33 PM | Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4/A | |
09/04/2024
8:33 PM | Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
| Form 144/A | |
09/04/2024
8:40 PM | BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
8:40 PM | Birchler Brian (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
8:41 PM | Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
8:19 PM | Ionis Pharmaceuticals (Subject)
Swayze Eric (Reporting)
| Form 144/A | |
09/04/2024
8:20 PM | Ionis Pharmaceuticals (Subject)
Schneider Eugene (Reporting)
| Form 144/A | |
09/04/2024
8:21 PM | Geary Richard S (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144/A | |
09/04/2024
8:02 PM | Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
| Form 4/A | |
09/04/2024
8:06 PM | Ionis Pharmaceuticals (Issuer)
Schneider Eugene (Reporting)
| Form 4/A | |
09/04/2024
8:11 PM | Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
| Form 4/A | |
09/04/2024
8:13 PM | HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4/A | |
09/04/2024
7:51 PM | Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
| Form 4/A | |
09/04/2024
7:52 PM | Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
| Form 4/A | |
09/04/2024
7:42 PM | BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4/A | |
09/04/2024
7:42 PM | Cadoret-Manier Onaiza (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4/A | |
09/03/2024
6:18 PM | Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
4:27 PM | Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2024
2:35 PM | Ionis Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/01/2024
10:15 AM | Ionis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Has Trump Finally Gone Too Far? (Ad) Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks.
It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives.
But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars.
And here's the good news. Register For The Webinar To Discover |
07/17/2024
4:02 PM | BERTHELSEN SPENCER R (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
4:02 PM | Diaz Allene M. (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
4:02 PM | HERMAN JOAN E (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
4:02 PM | Ionis Pharmaceuticals (Issuer)
KLEIN JOSEPH III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
4:03 PM | Ionis Pharmaceuticals (Issuer)
LOSCALZO JOSEPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
4:03 PM | Ionis Pharmaceuticals (Issuer)
PARSHALL B LYNNE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
4:03 PM | Ionis Pharmaceuticals (Issuer)
WENDER JOSEPH H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2024
3:11 PM | Diaz Allene M. (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/03/2024
2:13 PM | Ionis Pharmaceuticals (Issuer)
YANG MICHAEL J. (Reporting)
| Form 4/A | |
07/03/2024
1:48 PM | Ionis Pharmaceuticals (Issuer)
WENDER JOSEPH H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
1:48 PM | Ionis Pharmaceuticals (Issuer)
YANG MICHAEL J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
1:47 PM | BERTHELSEN SPENCER R (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
1:47 PM | Diaz Allene M. (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
1:47 PM | Hayden Michael R (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
1:47 PM | HERMAN JOAN E (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
1:47 PM | Ionis Pharmaceuticals (Issuer)
KLEIN JOSEPH III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
1:47 PM | Ionis Pharmaceuticals (Issuer)
LOSCALZO JOSEPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
1:47 PM | Ionis Pharmaceuticals (Issuer)
PARSHALL B LYNNE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
4:52 PM | BERTHELSEN SPENCER R (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
8:29 AM | Ionis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2024
9:59 AM | BERTHELSEN SPENCER R (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2024
3:33 PM | Ionis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/31/2024
6:15 AM | Ionis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
4:25 PM | Ionis Pharmaceuticals (Issuer)
WENDER JOSEPH H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
3:55 PM | Ionis Pharmaceuticals (Issuer)
KLEIN JOSEPH III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
10:15 AM | Ionis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2024
3:50 PM | Ionis Pharmaceuticals (Filer)
| Form DEF 14A | |
04/25/2024
3:52 PM | Ionis Pharmaceuticals (Filer)
| Form DEFA14A | |
04/25/2024
3:53 PM | Ionis Pharmaceuticals (Filer)
| Form ARS | |
04/17/2024
4:16 PM | Birchler Brian (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
4:19 PM | Baroldi Joseph (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2024
7:59 PM | Baroldi Joseph (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/16/2024
7:50 PM | Birchler Brian (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/08/2024
5:04 AM | Ionis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
4:52 PM | Ionis Pharmaceuticals (Issuer)
Jenne Kyle (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/13/2024
4:52 PM | Ionis Pharmaceuticals (Issuer)
Jenne Kyle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
6:13 PM | BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
6:13 PM | Birchler Brian (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
6:13 PM | Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
6:13 PM | Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
6:13 PM | Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
8:10 AM | Ionis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/21/2024
3:38 PM | Ionis Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/21/2024
10:17 AM | Ionis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/20/2024
9:39 AM | Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
| Form 144/A | |
02/16/2024
6:47 PM | Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:34 PM | Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024
5:09 AM | BB BIOTECH AG (Filed by)
Ionis Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/02/2024
6:54 PM | BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:54 PM | Cadoret-Manier Onaiza (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Buy this coin BEFORE Inauguration Day … (Ad) Mark my words … Bitcoin is going to $100,000.
BEFORE Trump is inaugurated.
And I think it could reach $125,000 by the end of his first month in office. This could be his favorite coin. |
02/02/2024
6:54 PM | Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:55 PM | HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:55 PM | Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:55 PM | Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:55 PM | Ionis Pharmaceuticals (Issuer)
Schneider Eugene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:55 PM | Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
4:31 PM | Ionis Pharmaceuticals (Subject)
Swayze Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
4:34 PM | Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
4:21 PM | Cadoret-Manier Onaiza (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Free IONS Stock Alerts